It was also somewhat unexpected that PD-L1 expression, an established biomarker for predicting response to anti-PD1 therapy, was higher than whole-tumor irradiation in abscopal tumors from both GRID and GRID with ICI-treated mice by day 12 [5••]. The gene discussed is CD274; the disease is neoplasm.